City Developments Limited's (SGX:C09) Market Cap Surged S$284m Last Week, Private Companies Who Have a Lot Riding on the Company Were Rewarded
Dongcheng Pharmaceutical (002675.SZ) announced first-quarter results, net profit of 64.327 million yuan, an increase of 28.38%
Dongcheng Pharmaceutical (002675.SZ) released its report for the first quarter of 2024. During the reporting period, it achieved revenue of 647 million yuan, a year-on-year decrease of 23.90%. Net profit attributable to shareholders of listed companies was 64.327 million yuan, an increase of 28.38% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was $54.85 million, an increase of 29.40% over the previous year.
Wanxing Holdings (08093.HK): It is considering deregistering or selling all of its shares in Yupai Shenzhen
Wanxing Holdings (08093.HK) issued an announcement regarding a report published on a WeChat account on February 14, 2024. The report mentioned the signing ceremony of the proposed cooperation (“alleged cooperation”) between the company concerned and Yupai Group.
Alset International Launches Travel Joint Venture
Singapore Shares Fall Tracking Overnight Declines in Europe, US; IFast Climbs 2%
Singapore's Strait Times Index fell on Friday to end the week in red, tracking overnight declines in North American and European markets. During the day, the benchmark Singapore Strait Times Index ran
City Developments Repurchases Shares
City Developments (SGX:C09) bought back 469,500 shares in the open market on Thursday for SG$2.8 million or SG$6.03 apiece, a bourse disclosure confirmed on the same day. The company has so far repurc